Response to: 'Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease: case report' by Bader-Meunier et al
about
Response to: 'Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease: case report' by Bader-Meunier et al
description
2020 nî lūn-bûn
@nan
2020年の論文
@ja
2020年学术文章
@wuu
2020年学术文章
@zh
2020年学术文章
@zh-cn
2020年学术文章
@zh-hans
2020年学术文章
@zh-my
2020年学术文章
@zh-sg
2020年學術文章
@yue
2020年學術文章
@zh-hant
name
Response to: 'Effectiveness an ...... report' by Bader-Meunier et al
@en
type
label
Response to: 'Effectiveness an ...... report' by Bader-Meunier et al
@en
prefLabel
Response to: 'Effectiveness an ...... report' by Bader-Meunier et al
@en
P2093
P1476
Response to: 'Effectiveness an ...... report' by Bader-Meunier et al
@en
P2093
Guangbo Chen
Purvesh Khatri
Vivian E Saper
P356
10.1136/ANNRHEUMDIS-2020-217000
P577
2020-02-13T00:00:00Z